BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2955060)

  • 1. [Endocrinological study of Sertoli-Leydig cell tumor].
    Haruyama Y; Miyakawa I; Inoue H; Mori N
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):765-70. PubMed ID: 2955060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid production in vitro of a hilus cell tumor of the human ovary.
    Janson PO; Hamberger L; Damber JE; Dennefors B; Knutson F
    Obstet Gynecol; 1980 May; 55(5):662-5. PubMed ID: 7366926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian and peripheral steroid hormones in a case of Sertoli-Leydig cell tumor.
    Mango D; Scirpa P; Liberati M; Menini E; Fabiano A; Mancuso S
    J Endocrinol Invest; 1988; 11(7):521-5. PubMed ID: 2844882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonist.
    Lamberts SW; Timmers JM; Oosterom R; Verleun T; de Jong FH
    J Clin Endocrinol Metab; 1982 Feb; 54(2):450-4. PubMed ID: 6274906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertoli-Leydig cell tumor of the ovary with alpha-fetoprotein production.
    Tetu B; Ordóñez NG; Silva EG
    Arch Pathol Lab Med; 1986 Jan; 110(1):65-8. PubMed ID: 2416299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norethindrone inhibition of testosterone secretion by an ovarian Sertoli-Leydig cell tumor.
    Brumsted JR; Chapitis J; Riddick D; Gibson M
    J Clin Endocrinol Metab; 1987 Jul; 65(1):194-7. PubMed ID: 3584396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A testosterone-secreting, gonadotropin-responsive pure thecoma and polycystic ovarian disease.
    Givens JR; Andersen RN; Wiser WL; Donelson AJ; Coleman SA
    J Clin Endocrinol Metab; 1975 Nov; 41(5):845-53. PubMed ID: 171277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endocrine profile and electron microscopic study of ovarian androblastoma].
    Inoue S; Fukuda O; Koyama N; Furuki Y; Munemura M; Maeyama M; Mizumoto J; Miyayama Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1155-62. PubMed ID: 6096462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid biosynthesis in the Sertoli-Leydig cell tumor: effects of insulin and luteinizing hormone.
    Nagamani M; Stuart CA; Van Dinh T
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1738-43. PubMed ID: 2532472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective ovarian vein sampling can be crucial to localize a Leydig cell tumor: an unusual case in a postmenopausal woman.
    Ozgun MT; Batukan C; Turkyilmaz C; Dolanbay M; Mavili E
    Maturitas; 2008 Nov; 61(3):278-80. PubMed ID: 18930614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LH receptor in testosterone-producing ovarian tumor. In vivo and in vitro HCG-stimulated testosterone production.
    Gutierrez S; Bermudez M; Zylbersztein C; Naredo E; Illanes L; Scaglia HE
    Eur J Gynaecol Oncol; 1983; 4(3):182-91. PubMed ID: 6313366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AFP-producing Sertoli-Leydig cell tumor of the ovary.
    Sekiya S; Inaba N; Iwasawa H; Kobayashi O; Takamizawa H; Matsuzaki O; Nagao K
    Arch Gynecol; 1985; 236(3):187-96. PubMed ID: 2409934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An alpha-fetoprotein producing Sertoli-Leydig cell tumor--a case report].
    Taniyama K; Suzuki H; Hara T; Yokoyama S; Tahara E
    Gan No Rinsho; 1989 Jan; 35(1):107-13. PubMed ID: 2466136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum alpha-fetoprotein associated with Sertoli-Leydig cell tumors of the ovary.
    Mann WJ; Chumas J; Rosenwaks Z; Merrill JA; Davenport D
    Obstet Gynecol; 1986 Jan; 67(1):141-4. PubMed ID: 2415889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid section patterns of a hilus cell tumor of the ovary.
    Nagamani M; Gonzalez-Vitale JC
    Obstet Gynecol; 1981 Oct; 58(4):521-7. PubMed ID: 7279348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment: report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma.
    Regnier C; Bennet A; Malet D; Guez T; Plantavid M; Rochaix P; Monrozies X; Louvet JP; Caron P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3074-7. PubMed ID: 12107203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphological and endocrinological study of ovarian arrhenoblastoma (author's transl)].
    Takakura K; Okamura H; Aso T; Takenaka A; Matsuoka M; Kanzaki H; Suzuki A; Nishimura T
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):961-8. PubMed ID: 6272528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined dexamethasone suppression and chorionic gonadotrophin stimulation test in the diagnosis of androgenic functional ovarian tumors].
    Lehmann WD; Lauritzen C
    Geburtshilfe Frauenheilkd; 1972 Nov; 32(11):913-21. PubMed ID: 4345633
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and resection of an oral contraceptive-suppressible Sertoli-Leydig cell tumor with preservation of fertility and a 7-year follow-up.
    Haning RV; Loughlin J; Shapiro SS
    Obstet Gynecol; 1989 May; 73(5 Pt 2):901-5. PubMed ID: 2523030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertoli-Leydig cell tumor of the ovary: a rare cause of amenorrhea.
    Larsen WG; Felmar EA; Wallace ME; Frieder R
    Obstet Gynecol; 1992 May; 79(5 ( Pt 2)):831-3. PubMed ID: 1565381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.